SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-17-065932
Filing Date
2017-12-29
Accepted
2017-12-29 17:22:35
Documents
2
Group Members
TECHNION INVESTMENT OPPORTUNITIES FUND L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G tv482301_sc13g.htm SC 13G 62638
2 EXHIBIT 1 tv482301_ex1.htm EX-99.1 5363
  Complete submission text file 0001144204-17-065932.txt   69865
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-56243 | Film No.: 171282719
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address TECHNION CITY, MALAT BLDG., 5TH FLOOR HAIFA L3 3200003
Business Address TECHNION CITY, MALAT BLDG., 5TH FLOOR HAIFA L3 3200003 972-4-829-4851
Technion Research & Development Foundation Ltd. (Filed by) CIK: 0001691391 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 0930
Type: SC 13G